只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 140 | US$542.75 | US$75,984.43 | 211,689 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 280 | US$555.05 | US$155,414.00 | 209,329 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 110 | US$543.79 | US$59,817.22 | 211,579 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 545 | US$544.71 | US$296,869.13 | 211,034 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 275 | US$545.71 | US$150,070.03 | 210,759 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 269 | US$547.08 | US$147,164.20 | 210,490 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 680 | US$547.70 | US$372,434.64 | 209,810 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 47 | US$548.87 | US$25,796.98 | 209,763 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 153 | US$550.01 | US$84,152.11 | 209,610 | SEC |
| 2026-07-20 2026-07-20 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sibold William John Director,Officer · President and CEO | 卖出（S） | 1 | US$550.72 | US$550.72 | 209,609 | SEC |
| 2026-06-01 2026-06-01 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Soergel David Officer · Chief Medical Officer | 卖出（S） | 1,042 | US$495.74 | US$516,561.08 | 10,033 | SEC |
| 2026-05-22 2026-05-22 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S Director | 卖出（S） | 80 | US$519.98 | US$41,598.40 | 22,015 | SEC |
| 2026-05-22 2026-05-22 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S Director | 卖出（S） | 782 | US$518.76 | US$405,670.32 | 22,095 | SEC |
| 2026-05-22 2026-05-22 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S Director | 卖出（S） | 1,497 | US$517.59 | US$774,832.23 | 22,877 | SEC |
| 2026-05-22 2026-05-22 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S Director | 卖出（S） | 723 | US$516.87 | US$373,697.01 | 24,374 | SEC |
| 2026-05-22 2026-05-22 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S Director | 卖出（S） | 657 | US$515.92 | US$338,959.44 | 25,097 | SEC |
| 2026-05-22 2026-05-22 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S Director | 卖出（S） | 343 | US$514.67 | US$176,531.81 | 25,754 | SEC |
| 2026-05-22 2026-05-22 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S Director | 卖出（S） | 40 | US$512.97 | US$20,518.80 | 26,097 | SEC |
| 2026-05-22 2026-05-22 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S Director | 卖出（S） | 439 | US$512.50 | US$224,987.50 | 26,137 | SEC |
| 2026-05-22 2026-05-22 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S Director | 卖出（S） | 610 | US$511.40 | US$311,954.00 | 26,576 | SEC |
| 2026-05-22 2026-05-22 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S Director | 卖出（S） | 151 | US$510.36 | US$77,064.36 | 27,186 | SEC |
| 2026-05-22 2026-05-22 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S Director | 卖出（S） | 40 | US$506.68 | US$20,267.20 | 27,657 | SEC |
| 2026-05-22 2026-05-22 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Levy Richard S Director | 卖出（S） | 320 | US$508.24 | US$162,636.80 | 27,337 | SEC |
| 2026-05-18 2026-05-18 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Soergel David Officer · Chief Medical Officer | 卖出（S） | 844 | US$515.90 | US$435,419.60 | 11,075 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| MDGL | 233,004.8788 | 1,968.0291 | 347,423.4821 | 67.07% | B, Q, N |